Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
The CEE pharmaceutical and healthcare sector demonstrates remarkable resilience amid regional economic pressures, with each country adopting distinct strategies to address similar challenges. The overall market continues its growth trajectory, though ...
View more details
Poland's healthcare and pharmaceutical sector is dynamic and rapidly evolving, marked by innovation, resilience, and a growing global presence despite substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has ...
View more details
Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. ...
View more details
Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. ...
View more details
Although quite different in terms of political and economic systems, the Emerging Europe countries share certain similarities when it comes to their demographic situation and health profile. With the exception of Turkey, whose average birth rate is ...
View more details
The Polish pharmaceutical market is the largest in Central Europe and the sixth largest in the EU. It is one of the strategic sectors of the Polish economy, contributing to 1.33% of GDP. It is made up of companies dealing in the production ...
View more details
In 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...
View more details